Standalone Financial Results, Limited Review Report For June 30, 2016 (Result)

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Combat Drugs Limited

Regd. Off: 9-109/9, Plot No.112, Road No.14, Gayatri Nagar, Bouduppal, R.R.District -500039, TS
Ph: +91-40-66200100 / 65523363
Url: www.combatdrugs.in Email: info@combatdrugs.in
CIN No.: L24230TG1986PLC006781
TIN: 36690236431
D.L.No.: TG/15/04/2016-14766

To,
The General Manager
Department of Corporate Services
BSE Limited
P. J. Towers, Dalal Street,
Mumbai 400001

13/08/2016

Sir,
Sub:

Outcome of Board Meeting Approval of Quarterly Results


(Quarter ended 30th June, 2016)

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, this is to inform you that at the meeting of
the Board of Directors of the company held today ie; 13th August, 2016, the Statement of
Un-Audited Financial Results for the quarter ended 30th June, 2016 was approved and taken
on record along with the Limited Review Report for the period issued by the Statutory
Auditors of the company.
Please find enclosed the following in respect of the above said:
1. Statement of Un-Audited Financial Results for the Quarter ended 30th June, 2016.
2. Limited Review Report of the Auditors on Quarterly Financial Results pursuant to the
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
This is for your information and records.
Thanking You
Yours Sincerely,
For COMBAT DRUGS LIMITED
Kiran Kumar K
COMPLIANCE OFFICER

You might also like